Skip to content

Studying the effect of treating hypopigmented scars with prostaglandin analogs throughfractional erbium yag laser assisted drug delivery

Studying the effect of treating hypopigmented scars with prostaglandin analogs throughfractional erbium yag laser assisted drug deliveryDuring the years 2024 to 2025 in patients referred to the laser department of Razi Hospital in Tehran

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241016063390N1
Enrollment
10
Registered
2024-12-13
Start date
2024-12-21
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypopigmented scar. Scar conditions and fibrosis of skin

Interventions

Intervention 1: Intervention group: On the treatment side, fractional Erbium:YAG 2490nm laser treatment will be performed on one half of the scar with the drug delivery of prostaglandin analog. Interv

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: People aged 15 to 65 years with hypopigmented scars Signing a voluntary agreement The length of the scar is at least 3 cm No previous treatments for scars

Exclusion criteria

Exclusion criteria: Age below 15 years and above 65 years Pregnancy or breastfeeding Uncontrolled systemic disease Photosensitivity Blepharoplasty scar

Design outcomes

Primary

MeasureTime frame
Repigmentation of hypopigmented scars. Timepoint: Laser treatment is done in three sessions with intervals of 3 to 4 weeks, and the patient will continue to use Bimatoprost for 7 days after the laser on the half of the lesion that was subjected to drug delivery during the laser session. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahin Hamzelou

Tehran University of Medical Sciences

dr.hamzelou@gmail.com+98 21 5288 8282

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026